250 related articles for article (PubMed ID: 32591397)
21. Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice.
Lalani AI; Moore CR; Luo C; Kreider BZ; Liu Y; Morse HC; Xie P
J Immunol; 2015 Jan; 194(1):334-48. PubMed ID: 25422508
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.
Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K
Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556
[TBL] [Abstract][Full Text] [Related]
23. TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation.
Bishop GA; Stunz LL; Hostager BS
Front Immunol; 2018; 9():2161. PubMed ID: 30319624
[TBL] [Abstract][Full Text] [Related]
24. A novel interaction between protein kinase D and TNF receptor-associated factor molecules regulates B cell receptor-CD40 synergy.
Haxhinasto SA; Bishop GA
J Immunol; 2003 Nov; 171(9):4655-62. PubMed ID: 14568940
[TBL] [Abstract][Full Text] [Related]
25. Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells.
Michel M; Wilhelmi I; Schultz AS; Preussner M; Heyd F
J Biol Chem; 2014 May; 289(19):13651-60. PubMed ID: 24671418
[TBL] [Abstract][Full Text] [Related]
26. Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination.
Chen Z; Getahun A; Chen X; Dollin Y; Cambier JC; Wang JH
J Immunol; 2015 Dec; 195(11):5461-5471. PubMed ID: 26500350
[TBL] [Abstract][Full Text] [Related]
27. TOLL-like receptor ligands stimulate aberrant class switch recombination in early B cell precursors.
Edry E; Azulay-Debby H; Melamed D
Int Immunol; 2008 Dec; 20(12):1575-85. PubMed ID: 18974086
[TBL] [Abstract][Full Text] [Related]
28. Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF.
Frasca D; Riley RL; Blomberg BB
Exp Gerontol; 2007 Mar; 42(3):192-203. PubMed ID: 17067770
[TBL] [Abstract][Full Text] [Related]
29. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.
He JQ; Saha SK; Kang JR; Zarnegar B; Cheng G
J Biol Chem; 2007 Feb; 282(6):3688-94. PubMed ID: 17158868
[TBL] [Abstract][Full Text] [Related]
30. Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice.
Perez-Chacon G; Adrados M; Vallejo-Cremades MT; Lefebvre S; Reed JC; Zapata JM
Front Immunol; 2018; 9():3114. PubMed ID: 30687320
[TBL] [Abstract][Full Text] [Related]
31. TNF receptor-associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling.
Xie P; Kraus ZJ; Stunz LL; Liu Y; Bishop GA
J Immunol; 2011 Jan; 186(1):143-55. PubMed ID: 21084666
[TBL] [Abstract][Full Text] [Related]
32. B cell TLRs and induction of immunoglobulin class-switch DNA recombination.
Pone EJ; Xu Z; White CA; Zan H; Casali P
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2594-615. PubMed ID: 22652800
[TBL] [Abstract][Full Text] [Related]
33. Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation.
Hostager BS; Bishop GA
J Immunol; 1999 Jun; 162(11):6307-11. PubMed ID: 10352240
[TBL] [Abstract][Full Text] [Related]
34. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
He L; Grammer AC; Wu X; Lipsky PE
J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
[TBL] [Abstract][Full Text] [Related]
35. Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.
Vilen BJ; Burke KM; Sleater M; Cambier JC
J Immunol; 2002 May; 168(9):4344-51. PubMed ID: 11970976
[TBL] [Abstract][Full Text] [Related]
36. One-step generation of monoclonal B cell receptor mice capable of isotype switching and somatic hypermutation.
Jacobsen JT; Mesin L; Markoulaki S; Schiepers A; Cavazzoni CB; Bousbaine D; Jaenisch R; Victora GD
J Exp Med; 2018 Oct; 215(10):2686-2695. PubMed ID: 30181412
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer.
Zapata JM; Llobet D; Krajewska M; Lefebvre S; Kress CL; Reed JC
Blood; 2009 May; 113(19):4595-603. PubMed ID: 19074733
[TBL] [Abstract][Full Text] [Related]
38. The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development.
Lin WW; Yi Z; Stunz LL; Maine CJ; Sherman LA; Bishop GA
Sci Signal; 2015 Sep; 8(392):ra88. PubMed ID: 26329582
[TBL] [Abstract][Full Text] [Related]
39. Requirement of 8-mercaptoguanosine as a costimulus for IL-4-dependent mu to gamma1 class switch recombination in CD38-activated B cells.
Tsukamoto Y; Uehara S; Mizoguchi C; Sato A; Horikawa K; Takatsu K
Biochem Biophys Res Commun; 2005 Oct; 336(2):625-33. PubMed ID: 16143305
[TBL] [Abstract][Full Text] [Related]
40. Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile.
Liubchenko GA; Appleberry HC; Holers VM; Banda NK; Willis VC; Lyubchenko T
J Autoimmun; 2012 Jun; 38(4):293-303. PubMed ID: 22365785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
